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At countless points during any sort of scientific 
pursuit, there are many interesting questions that 
are raised that might pique the interest of those with 
curious minds. Questions aren't hard to come by, 
then, but the task becomes this: how might a 
scientist begin to explore a brand new question that 
they don't really know anything about? As it turns 
out, there are many ways to explore scientific data 
through public and open-source research tools. Over 
the course of the summer, I found one question in 
particular that grabbed me: pancreatic cancer—as of 
today, one of the deadliest, least-understood, and 
most hopeless cancers that exists—is tied 
astonishingly tightly to mutations in one particular 
gene called KRAS. Why pancreatic cancer and that 
gene? KRAS is expressed more in other types of 
tissue in the body, but cancers in those tissues are 
less commonly tied to KRAS mutations. For some 
reason, despite not seeming to rely heavily on 
expression of the KRAS gene, mutations in KRAS 
contribute to over 90% of pancreatic cancers. Why? 
That's what I set out to understand, and this was the 
path I followed to explore a question with the whole 
world of science in front of me.
The first place to start with any question in the 
sciences is an exploration of the current literature 
on and around the subject. Maybe the question of 
interest has already been answered! If not, it’s 
always a great idea to get familiar with the current 
state of research and to get an idea of where to 
start pursuing the question. PubMed and the NCBI 
websites are great places to do both broad and 
advanced literature searches. I was able to find a 
number of informative articles about KRAS and its 
significance to pancreatic cancer, but no concrete 
answers. Armed with a better understanding of the 
issue, then, I had a place to start from.
There are so many useful, public online tools to use in 
scientific research. Given that my question was about 
genomics and cancer, I decided to start with a resource 
tailored to my needs: The Cancer Genome Atlas. TCGA is 
a massive collection of data and analysis from hundreds 
of sources and studies, all compiled into a publicly 
accessible, free website. I focused in on two particular 
subjects using this tool: pancreatic cancer and the KRAS 
gene.
I wanted to know exactly what the KRAS gene does and 
why mutations in it so often lead to cancer, especially in 
the pancreas. This led me from The Cancer Genome Atlas 
to another online atlas: The Human Protein Atlas. I, of 
course, was interested in KRAS, specifically its function 
and its significance to the pancreas. What I found 
surprised me. The KRAS gene is expressed at much 
higher levels in tissue other than the pancreas, especially 
in the gastrointestinal tract. Despite that, KRAS 
mutations are tied to significantly less cancer in the 
intestines than in the pancreas. Why? I had found out 
important information, but my question seemed to be 
getting stranger.
The last of the unique online resources I used to pursue 
this question is called cBioPortal. This tool helped provide 
visualizations of data from hundreds of pancreatic cancer 
cases, including demographic statistics, survivability rates, 
and, most relevant to me and my research, the number 
and significance of the various mutations found across 
the cases. A combination of KRAS and TP53 (a tumor-
suppressing gene) were far and away the most prevalent 
mutations. A further dive into the cBioPortal website 
allowed me to examine in detail each mutation, including 
multiple different mutations within the KRAS gene, and 
their specific effects and results. 
With the new information I’d gathered, I was no closer to 
being able to answer my question. In fact, the more I had 
found out about KRAS, the more perplexing it seemed 
that it should have such a strong tie to pancreatic cancer. 
After another literature search, my rather inconclusive 
conclusions had been confirmed. A number of articles 
looked at similar things, and the consensus is that nobody 
knows yet quite why KRAS mutations are so crucial to 
pancreatic cancer. What is undeniable is that there is a 
connection, and a shockingly strong one, between the 
two. The mystery makes the question all the more 
compelling, and it continues to be the focus of research, 
study, and experimentation from scientists all over the 
world. Though my research did not unlock all the secrets 
of cancer to me, I was able to gain invaluable experience 
in freely exploring a specific scientific question using 
resources freely available to anyone. The tools are out 
there waiting for you, and all you need to use them is a 
question and a curious mind.
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